Search research articles
Contact Us
Filters
Showing results (31-40 of 40) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 40 results.
Clinical Immunology (Orlando, Fla.)
|
July 24, 2018
Anti-polysaccharide and anti-diphtheria protective antibodies after 13-valent pneumococcal conjugate vaccination in rheumatoid arthritis patients under immunosuppressive therapy
Sara Caporuscio, Roberto Ieraci, Guido Valesini, et al.
Rheumatology and Therapy
|
August 23, 2024
Clinical and Ultrasonographic Remission in Bio-naïve and Bio-failure Patients with Rheumatoid Arthritis at 24 Weeks of Upadacitinib Treatment: The UPARAREMUS Real-Life Study
Andrea Picchianti Diamanti, Maria Sofia Cattaruzza, Simonetta Salemi, et al.
Vaccine
|
October 2, 2018
Tetanus-diphtheria vaccination in adults: the long-term persistence of antibodies is not dependent on polyclonal B-cell activation and the defective response to diphtheria toxoid re-vaccination is associated to HLADRB1∗01
Claudia Ferlito, Roberto Biselli, Sabrina Mariotti, et al.
Frontiers in Immunology
|
March 21, 2022
Kinetics of the B- and T-Cell Immune Responses After 6 Months From SARS-CoV-2 mRNA Vaccination in Patients With Rheumatoid Arthritis
Chiara Farroni, Andrea Picchianti-Diamanti, Alessandra Aiello, et al.
Frontiers in Immunology
|
October 1, 2021
ImmunosuppressiveTherapies Differently Modulate Humoral- and T-Cell-Specific Responses to COVID-19 mRNA Vaccine in Rheumatoid Arthritis Patients
Andrea Picchianti-Diamanti, Alessandra Aiello, Bruno Laganà, et al.
Clinical Immunology (Orlando, Fla.)
|
June 20, 2017
Lack of evidence for post-vaccine onset of autoimmune/lymphoproliferative disorders, during a nine-month follow-up in multiply vaccinated Italian military personnel
Claudia Ferlito, Vincenzo Barnaba, Sergio Abrignani, et al.
Biomedicines
|
January 22, 2021
Immunogenicity of Viral Vaccines in the Italian Military
Claudia Ferlito, Roberto Biselli, Vincenzo Visco, et al.
Biomedicines
|
January 21, 2022
Safety of Multiple Vaccinations and Durability of Vaccine-Induced Antibodies in an Italian Military Cohort 5 Years after Immunization
Claudia Ferlito, Vincenzo Visco, Roberto Biselli, et al.
Vaccines
|
November 25, 2023
Older Age, a High Titre of Neutralising Antibodies and Therapy with Conventional DMARDs Are Associated with Protection from Breakthrough Infection in Rheumatoid Arthritis Patients after the Booster Dose of Anti-SARS-CoV-2 Vaccine
Andrea Picchianti-Diamanti, Assunta Navarra, Alessandra Aiello, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
November 3, 2022
Booster dose of SARS-CoV-2 messenger RNA vaccines strengthens the specific immune response of patients with rheumatoid arthritis: A prospective multicenter longitudinal study
Chiara Farroni, Alessandra Aiello, Andrea Picchianti-Diamanti, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 40) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 40 results.
Clinical Immunology (Orlando, Fla.)
|
July 24, 2018
Anti-polysaccharide and anti-diphtheria protective antibodies after 13-valent pneumococcal conjugate vaccination in rheumatoid arthritis patients under immunosuppressive therapy
Sara Caporuscio, Roberto Ieraci, Guido Valesini, et al.
Rheumatology and Therapy
|
August 23, 2024
Clinical and Ultrasonographic Remission in Bio-naïve and Bio-failure Patients with Rheumatoid Arthritis at 24 Weeks of Upadacitinib Treatment: The UPARAREMUS Real-Life Study
Andrea Picchianti Diamanti, Maria Sofia Cattaruzza, Simonetta Salemi, et al.
Vaccine
|
October 2, 2018
Tetanus-diphtheria vaccination in adults: the long-term persistence of antibodies is not dependent on polyclonal B-cell activation and the defective response to diphtheria toxoid re-vaccination is associated to HLADRB1∗01
Claudia Ferlito, Roberto Biselli, Sabrina Mariotti, et al.
Frontiers in Immunology
|
March 21, 2022
Kinetics of the B- and T-Cell Immune Responses After 6 Months From SARS-CoV-2 mRNA Vaccination in Patients With Rheumatoid Arthritis
Chiara Farroni, Andrea Picchianti-Diamanti, Alessandra Aiello, et al.
Frontiers in Immunology
|
October 1, 2021
ImmunosuppressiveTherapies Differently Modulate Humoral- and T-Cell-Specific Responses to COVID-19 mRNA Vaccine in Rheumatoid Arthritis Patients
Andrea Picchianti-Diamanti, Alessandra Aiello, Bruno Laganà, et al.
Clinical Immunology (Orlando, Fla.)
|
June 20, 2017
Lack of evidence for post-vaccine onset of autoimmune/lymphoproliferative disorders, during a nine-month follow-up in multiply vaccinated Italian military personnel
Claudia Ferlito, Vincenzo Barnaba, Sergio Abrignani, et al.
Biomedicines
|
January 22, 2021
Immunogenicity of Viral Vaccines in the Italian Military
Claudia Ferlito, Roberto Biselli, Vincenzo Visco, et al.
Biomedicines
|
January 21, 2022
Safety of Multiple Vaccinations and Durability of Vaccine-Induced Antibodies in an Italian Military Cohort 5 Years after Immunization
Claudia Ferlito, Vincenzo Visco, Roberto Biselli, et al.
Vaccines
|
November 25, 2023
Older Age, a High Titre of Neutralising Antibodies and Therapy with Conventional DMARDs Are Associated with Protection from Breakthrough Infection in Rheumatoid Arthritis Patients after the Booster Dose of Anti-SARS-CoV-2 Vaccine
Andrea Picchianti-Diamanti, Assunta Navarra, Alessandra Aiello, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
November 3, 2022
Booster dose of SARS-CoV-2 messenger RNA vaccines strengthens the specific immune response of patients with rheumatoid arthritis: A prospective multicenter longitudinal study
Chiara Farroni, Alessandra Aiello, Andrea Picchianti-Diamanti, et al.
Page
of 4